Because we found that MGMT is involved in RAD51 expression and BRCA1 phosphorylation in NPC cells treated with CDDP, we assessed whether MGMT expression can modulate CDDP-induced DSBs in NPC cells. The gene discussed is MGMT; the disease is nasopharyngeal carcinoma.